RHON-KLINIKUM AG has announced a stable business performance for the first half of 2026, with consolidated revenue slightly rising to EUR 863.6 million from EUR 833.5 million in the prior-year period. EBITDA improved to EUR 57.0 million (H1 2025: EUR 46.7 million), and consolidated profit reached EUR 22.5 million (H1 2025: EUR 14.7 million). The results were partly affected by transformation costs established to offset higher personnel and material costs from previous years. Patient numbers increased by 9% to 513,700, reflecting the group's ongoing commitment to expanding regional healthcare provision.
The company is investing in state-of-the-art medical technology at all sites and is actively forging regional cooperation networks. In Hesse, Universitatsklinikum Marburg and Lungenfachklinik Immenhausen have entered a strategic partnership to improve lung patient care. In Brandenburg, a new child protection emergency service at the Frankfurt (Oder) site has been launched, supported by cooperation agreements with the City of Frankfurt (Oder) and the District of Oder-Spree to ensure seamless coordination for affected children and adolescents.
Dr. Gunther K. WeiB, member of the Board of Management, emphasized the importance of regional networks: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently.”
However, the company faces significant challenges from recent legislative changes. Dr. Stefan Stranz, also on the Board of Management, criticized the Statutory Health Insurance Contribution Rate Stabilization Act: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.”
For the full year 2026, RHON-KLINIKUM expects revenues of EUR 1.7 billion (plus or minus 5%) and EBITDA between EUR 110 million and EUR 125 million. The company also anticipates moderate improvements in non-financial indicators like case numbers and cost weights. However, the forecast is subject to considerable uncertainties due to the unfolding legislative process, including the Hospital Reform Adjustment Act (KHAG) and the GKV-BStabG, which aim to enhance quality and efficiency but may increase financial pressure on hospitals in the short term.
Ongoing global crises and economic impacts, such as higher prices and supply bottlenecks, add to the volatility. As the company navigates these regulatory and economic challenges, its strategic focus on regional networks and investment in medical technology positions it to maintain comprehensive, high-quality care, particularly in rural areas. The full interim report is available on the company's website.
